|
|
|
|
|
27.02.26 - 02:24
|
Asahi Kasei to Acquire German Drug Developer Aicuris (Nippon)
|
|
|
Tokyo, Feb. 27 (Jiji Press)--Asahi Kasei Corp. has said it will acquire German pharmaceutical developer Aicuris Anti-Infective Cures AG for some 780 million euros. The major Japanese chemical maker will obtain all outstanding Aicuris shares through a U.S. subsidiary, planning to complete the acquisition in April-June. Asahi Kasei aims to expand profits in the medical field, a growth area for......
|
|
|
|
|
26.02.26 - 15:01
|
Taiwan President Honors Baseball Legend Oh (Nippon)
|
|
|
Taipei, Feb. 26 (Jiji Press)--Taiwanese President Lai Ching-te on Thursday bestowed the Order of Brilliant Star with Special Grand Cordon on legendary professional baseball player Sadaharu Oh in honor of his contributions to cultural exchanges between Japan and Taiwan through the sport. Oh, 85, chairman of Japanese professional baseball club Fukuoka SoftBank Hawks, called for cooperation be......
|
|
|
|
|
26.02.26 - 13:33
|
Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris (Business Wire)
|
|
|
Advancing Expansion in Severe Infectious Disease and Leveraging Existing Global Infrastructure to Drive Long-Term GrowthCHELMSFORD, Mass. & TOKYO--(BUSINESS WIRE)--Asahi Kasei announced it has entered into a definitive agreement to acquire all issued shares of Aicuris Anti-infective Cures AG, a German-based biopharmaceutical company, for approximately €780 million*. This transaction expands Asahi Kasei's specialty pharmaceutical platform further into severe infectious diseases and is expected to close in the first quarter of fiscal 2026, subject to customary conditions.
Asahi Kasei expects the acquisition to contribute positively to operating income after amortization of goodwill and other intangible assets from fiscal 2028 onward.
The acquisition advances Asahi Kasei's strategy to build a focused, sustainable specialty pharmaceutical platform serving immunocompromised and medically complex patient populations. Severe infectious diseases represent an area where Asahi Kasei already maintains a presence...
|
|
|
26.02.26 - 13:06
|
Nomination Committee′s proposal regarding Board of Directors of NCC AB for 2026 (Cision)
|
|
|
NCC's Nomination Committee proposes the election of seven Board members, with no deputies, and the re-election of Alf Göransson as Chairman of the Board, for resolution at the Annual General Meeting (AGM). Niklas Persson, Executive Vice President and Business Unit Managing Director at Hitachi Energy, is proposed as a new member. Simon de Ch'teau has declined re-election. The re-election of all other Board members is proposed.
Alf Göransson was elected Chairman in 2020 and has been a Board member since 2019. The other Board members who are proposed for re-election are Mats Jönsson (member...
|
|
|
26.02.26 - 11:03
|
SHINE Completes $240 Million in Recent Funding Led by Dr. Patrick Soon-Shiong, Founder of NantWorks, Who Joins Board of Directors (PR Newswire)
|
|
|
Fidelity Management & Research Company, Sumitomo Corporation of Americas, Pelican Energy Partners, Deerfield Management and Oaktree Capital Management participated in the Financing Round JANESVILLE, Wis., Feb. 26, 2026 /PRNewswire/ -- SHINE Technologies, a nuclear fusion company, today......
|
|
|
|
|
|
|
26.02.26 - 08:12
|
Asahi Kasei übernimmt Aicuris für 780 Mio. EUR (GoingPublic)
|
|
|
Bildnachweis: ©crevis – stock.adobe.com. 780 Mio. Euro für ein deutsches Antiinfektiva-Biotech: Asahi Kasei übernimmt die in Wuppertal ansässige Aicuris vollständig – abgewickelt über die US-Tochter Veloxis Pharmaceuticals. Mit dem etablierten […]
Der Beitrag Asahi Kasei übernimmt Aicuris für 780 Mio. EUR erschien zuerst auf GoingPublic.de....
|
|
|
26.02.26 - 08:09
|
Übernahme! Deutsche Biotech-Firma wird aufgekauft (Der Aktionaer)
|
|
|
Das Übernahme-Karussell im Biotech-Sektor bleibt mächtig in Bewegung. Veloxis Pharmaceuticals, eine US-amerikanische Tochtergesellschaft des japanischen Technologie-Konzerns Asahi Kasei, will die deutsche Biotechnologie-Gesellschaft AiCuris schlucken und legt dafür satte 920 Millionen Dollar auf den Tisch....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.02.26 - 06:06
|
SoftBank leads US-Japan alliance investing US$33.3B in Trump gas power plant (Digitimes)
|
|
|
SoftBank Group (SBG) is spearheading an investment alliance to develop a US-based natural gas-fired power plant project valued at US$33.3 billion, aiming to support infrastructure demands driven by artificial intelligence (AI). This initiative is one of three projects launched under the US-Japan trade agreement signed with President Donald Trump in 2025....
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
